• Clinical Trials
  • Partnerships
  • Media
  • Careers
  • Contact
  • Science & Medicine
    • Scientific Focus
    • Pipeline
    • Medicines
  • Patients & Families
    • Diseases & Conditions
    • Patient Resources
    • Clinical Trials
    • Managed Access
  • Responsibility
    • Access
    • Funding Requests
    • Disclosures
  • About Us
    • Leadership
    • Board of Directors
  • Investors
    • Press Releases
    • Events & Presentations
    • 2021 Annual Meeting
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Contact Us
  • +
  • Science & Medicine
    • Scientific Focus
    • Pipeline
    • Medicines
  • Patients & Families
    • Diseases & Conditions
    • Clinical Trials
    • Patient Resources
    • Managed Access
  • Responsibility
    • Access
    • Funding Requests
    • Disclosures
  • About Us
    • Leadership
    • Board of Directors
    • Partnerships
  • Investors
    • Press Releases
    • Events & Presentations
    • 2021 Annual Meeting
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Contact Us
  • Careers
  • Media
  • Contact
About Us

Board of Directors

  • David Chiswell, Ph.D. – Chairman
    Former CEO, Cambridge Antibody Technology (CAT), Nabriva Therapeutics and Kymab; Currently Chairman, Epsilogen and Board Member of Avillion Bond 2 Development 2 GP
  • Anne Klibanski, M.D.
    President and CEO, Mass General Brigham; Laurie Carrol Guthart Professor of Medicine, Harvard Medical School
  • Michael Gutch, Ph.D.
    Chief Financial Officer, Noema Pharma
  • Stephanie S. Okey, M.S.
    Former Senior Vice President, Head of North America, Rare Diseases, Genzyme, a Sanofi Company
  • Davey S. Scoon
    Former CFO, Tom’s of Maine; Board of Trustees, Allianz Global Investors
  • Ron Cooper
    President and Chief Executive Officer
  • Site Map
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Contact

© 2022 Albireo Pharma, Inc.

YOU ARE NOW LEAVING ALBIREOPHARMA.COM

The link you have selected will take you outside of Albireo Pharma’s corporate website. The site you will be entering is intended for U.S. audiences only.

Go Back
Continue

YOU ARE NOW LEAVING ALBIREOPHARMA.COM

You are now leaving Albireo Pharma’s corporate website. Albireo does not control or endorse the content of this external site.

Go Back
Continue

YOU ARE NOW LEAVING ALBIREOPHARMA.COM

The link you have selected will take you outside of Albireo Pharma’s corporate website.

Go Back
Continue
+